Supplementary Material – Patient preferences for frontline therapies for Ph-positive acute lymphoblastic leukemia: a discrete choice experiment

https://doi.org/10.25402/FON.19235736

dataset

posted on 2022-02-25, 08:28 authored by Taylor & FrancisTaylor & Francis, Ashaye, Ajibade, Thomas, Caitlin, Dalal, Mehul, Kota, Vamsi, Krucien, Nicolas, Sae-Hau, Maria, Weiss, Elisa, Campbell, Scott, Marsh, Kevin

<div> <table> <tr> <td> <p><b>Table S1. Comparison of statistical performance across models</b></p> </td> </tr> </table> </div>

Funding

Takeda Development Center Americas, Inc.

History

Related Materials

1.
DOI - Is supplement to Patient preferences for frontline therapies for Ph-positive acute lymphoblastic leukemia: a discrete choice experiment

Usage metrics

Keywords

acute lymphoblastic leukemia discrete choice experiment hematologic neoplasms patient preference Philadelphia chromosome shared decision making tyrosine kinase inhibitor Cancer Therapy (excl. Chemotherapy and Radiation Therapy)

Licence

CC BY-NC-ND 4.0